Immune recognition of Candida albicans β-glucan by dectin-1

Journal of Infectious Diseases

Volumn 196, Issue 10, 2007, Pages 1565-1571

  Gow, Neil A R ^a   Netea, Mihai G ^b   Munro, Carol A ^a   Ferwerda, Gerben ^b   Bates, Steven ^a   Mora Montes, Héctor M ^a   Walker, Louise ^a   Jansen, Trees ^b   Jacobs, Liesbeth ^b   Tsoni, Vicky ^c   Brown, Gordon D ^c   Odds, Frank C ^a   Van Der Meer, Jos W M ^b   Brown, Alistair J P ^a   Kullberg, Bart Jan ^b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCAN; DECTIN 1; INTERLEUKIN 10; INTERLEUKIN 6; MANNAN; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN KINASE SYK; TUMOR NECROSIS FACTOR ALPHA; BETA GLUCAN RECEPTOR; BETA-GLUCAN RECEPTOR; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; NERVE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN RECOGNITION; ARTICLE; BACTERIAL CELL WALL; CANDIDA ALBICANS; CELL STIMULATION; CELL SURFACE; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; TH2 CELL; ANIMAL; CANDIDIASIS; DISEASE MODEL; IMMUNOLOGY; MICROBIOLOGY; MONONUCLEAR CELL; MOUSE MUTANT; PERITONEUM MACROPHAGE;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; DISEASE MODELS, ANIMAL; HUMANS; LEUKOCYTES, MONONUCLEAR; MACROPHAGES, PERITONEAL; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; RECEPTORS, IMMUNOLOGIC;

EID: 38449083793     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/523110     Document Type: Article

References (33)

1. Gudlaugsson O, Gillespie S, Lee K, et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 2003; 37:1172-7.
2. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39:309-17.
3. van 't Wout JW, Linde I, Leijh PCJ, van Furth R. Contribution of granulocytes and monocytes to resistance against experimental disseminated Candida albicans infections. Eur J Clin Microbiol Infect Dis 1988; 7:736-41.
4. Kullberg BJ, van 't Wout JW, van Furth R. Role of granulocytes in enhanced host resistance to Candida albicans induced by recombinant interleukin-1. Infect Immun 1990; 58:3319-24.
5. Marodi L, Korchak HM, Johnston RB Jr. Mechanisms of host defense against Candida species. 1. Phagocytosis by monocytes and monocytederived macrophages. J Immunol 1991; 146:2783-9.
6. Qian Q, Jutila MA, Van Rooijen N, Cutler JE. Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J Immunol 1994; 152:5000-8.
7. Netea MG, van Tits LJH, Curfs JH, et al. Increased susceptibility of TNF-α lymphotoxin-α double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans. J Immunol 1999; 163:1498-505.
8. Kaposzta R, Tree P, Marodi L, Gordon S. Characteristics of invasive candidiasis in gamma interferon- and interleukin-4-deficient mice: role of macrophages in host defense against Candida albicans. Infect Immun 1998; 66:1708-17.
9. Tonnetti L, Spaccapelo R, Cenci E, et al. Interleukin-4 and -10 exacerbate candidiasis in mice. Eur J Immunol 1995; 25:1559-65.
10. Tada H, Nemoto E, Shimauki H, et al. Saccharomyces cerevisiae- and Candida albicans-derived mannan induced production of tumor necrosis factor alpha by human monocytes in a CD14- and Toll-like receptor 4-dependent manner. Microbiol Immunol 2002; 46:503-12.
11. Netea MG, de Graaf C, Vonk A, Verschueren I, Van der Meer JW, Kullberg BJ. The role of Toll-like receptors in the defense against disseminated candidiasis. J Infect Dis 2002; 185:1483-9.
12. + regulatory T cells. J Immunol 2004; 172:3712-8.
13. Bellocchio S, Montagnoli C, Bozza S, et al. The contribution of Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol 2004; 172:3059-69.
14. Netea MG, Gow NA, Munro CA, et al. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J Clin Invest 2006; 116:1642-50.
15. Yamamoto Y, Klein TW, Friedman H. Involvement of mannose receptor in cytokine interleukin-1β (IL-1β), IL-6, and granulocytemacrophage colony-stimulating factor responses, but not in chemokine macrophage inflammatory protein 1β (MIP-1β), MIP-2, and KC responses, caused by attachment of Candida albicans to macrophages. Infect Immun 1997; 65:1077-82.
16. Jouault T, Ibata-Ombetta S, Takeuchi O, et al. Candida albicans phospholipomannan is sensed through Toll-like receptors. J Infect Dis 2003; 188:165-72.
17. Jouault T, El Abed-El Behi M, Martinez-Esparza M, et al. Specific recognition of Candida albicans by macrophages requires galectin-3 to discriminate Saccharomyces cerevisiae and needs association with TLR2 for signaling. J Immunol 2006; 177:4679-87.
18. Brown GD, Gordon S. A new receptor for β-glucans. Nature 2001; 413:36-7.
19. Brown GD, Herre J, Williams DL, Willment JA, Marshall AS, Gordon S. Dectin-1 mediates the biological effects of β-glucans. J Exp Med 2003; 197:1119-24.
20. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. Collaborative induction of inflammatory responses by dectin-1 and Tolllike receptor 2. J Exp Med 2003; 197:1107-17.
21. Taylor PR, Tsoni SV, Willment JA, et al. Dectin-1 is required for β-glucan recognition and control of fungal infection. Nat Immunol 2007; 8:31-8.
22. Saijo S, Fujikado N, Furuta T, et al. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat Immunol 2007; 8:39-46.
23. Endres S, Ghorbani R, Lonnemann G, Van der Meer JWM, Dinarello CA. Measurement of immunoreactive interleukin-1β from human mononuclear cells: optimization of recovery, intrasubject consistency, and comparison with interleukin-1α and tumor necrosis factor. Clin Immunol Immunopathol 1988; 49:424-38.
24. Drenth JPH, Van Uum SHM, Van Deuren M, Pesman GJ, Van der Ven-Jongekrijg J, Van der Meer JWM. Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-α and IL-1β production. J Appl Physiol 1995; 79:1497-1503.
25. Kullberg BJ, van 't Wout JW, Hoogstraten C, van Furth R. Recombinant interferon-γ enhances resistance to acute disseminated Candida albicans infection in mice. J Infect Dis 1993; 168:436-43.
26. Netea MG, Demacker PNM, Kullberg BJ, et al. Low-density lipoprotein receptor- deficient mice are protected against lethal endotoxinemia and severe gram-negative infections. J Clin Invest 1996; 97:1366-72.
27. Gantner BN, Simmons RM, Underhill DM. Dectin-1 mediates macrophage recognition of Candida albicans yeasts but not filaments. EMBO J 2005; 24:1277-86.
28. Rogers NC, Slack EC, Edwards AD, et al. Syk-dependent cytokine induction by dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity 2005; 22:507-17.
29. Gross O, Gewies A, Finger K, et al. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 2006; 442:651-6.
30. Klis FM, de Groot P, Hellingwerf K. Molecular organization of the cell wall of Candida albicans. Med Mycol 2001; 39(Suppl 1):1-8.
31. Wheeler RT, Fink GR. A drug-sensitive genetic network masks fungi from the immune system. PLoS Pathog 2006; 2:328-39.
32. Obayashi T, Yoshida M, Mori T, et al. Plasma (1 - >3)-β-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995; 345:17-20.
33. Odabasi Z, Paetznick VL, Rodriguez JR, Chen E, McGinnis MR, Ostrosky-Zeichner L. Differences in β-glucan levels in culture supernatants of a variety of fungi. Med Mycol 2006; 44:267-72.